alexa Oncology Clinical Trials|OMICS International|Clinical Trials

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Oncology Clinical Trials

In oncology clinical trials, the primary endpoint of the registration studies are often Progression Free Survival (PFS), which is by nature a subjective assessment as compared to the more definitive and objective assessment of overall survival. Regulatory agencies suggest that registration trials with subjective endpoints such as imaging could benefit from a Blinded Independent Central Review (BICR) of the clinical data. The BICR is a mechanism to eliminate bias in open labeled trials and to potentially increase accuracy and precision over site evaluation by providing better control of the review process. Process control is a major concern when dealing with a subjective and often complex assessment of imaging data, which are often the deterministic factors in PFS studies
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014